General
Showing 1281–1296 of 1897 results
-
Article: P18 Ibrutinib, the first available BTK inhibitor: single centre experience
€2.42 Add to cart -
Article: P19 EVALUATION OF AN AUTOMATED LIGHT TRANSMISSION AGGREGOMETRY
€2.42 Add to cart -
Article: P19 Receptor tyrosine kinase AXL: a potential new target in multiple myeloma
€2.42 Add to cart -
Article: P19 Vanishing bile duct syndrome associated with diffuse large B-cell lymphoma
€2.42 Add to cart -
Article: P2.01 Downregulation of cellular microRNA-150 is a new prognostic factor associated with a poor prognosis in Chronic Lymphocytic Leukemia patients
€2.42 Add to cart -
Article: P2.01 Evaluation of the Red Blood Cell Advanced Software Application on the CellaVision DM96
€2.42 Add to cart -
Article: P2.01 Functional evaluation of T cells generated from WT1-TCR transduced human hematopoietic stem cells using the OP9-DL1 coculture system
€2.42 Add to cart -
Article: P2.02 Belgian consensus on the diagnosis and management of Paroxysmal Nocturnal Hemoglobinuria
€2.42 Add to cart -
Article: P2.02 The value of SOX11 overexpression in the differential diagnosis of mantle cell lymphoma
€2.42 Add to cart -
Article: P2.03 Belgian Stop IMatinib trial
€2.42 Add to cart -
Article: P2.03 Evaluation of the Red Blood Cell Advanced Software Application on the CellaVision DM96
€2.42 Add to cart -
Article: P2.03 Immunomodulatory Drugs Restore Effector Cell Immune Functions In Myeloma Patients With Low Disease Burden After Autologous Stem Cell Transplantation
€2.42 Add to cart -
Article: P2.04 Application of a clot based assay to measure the procoagulant activity of stored allogeneic red blood cell concentrates
€2.42 Add to cart -
Article: P2.04 Immune impairments of the multiple myeloma bone-marrow mesenchymal stromal cells
€2.42 Add to cart -
Article: P2.04 Role of microvesicles derived from leukemic blast in DIC and thrombosis.
€2.42 Add to cart -
Article: P2.05 Global HDAC enzymatic activity is a strong marker of poor prognosis in Chronic Lymphocytic Leukemia
€2.42 Add to cart
